Posted on 09/07/2020
Uric acid predicts long‐term cardiovascular risk in Type 2 Diabetes but does not mediate the benefits of fenofibrate, according to findings from our FIELD study published in Diabetes, Obesity and Metabolism.
Congratulations to CTC co-authors Alicia Jenkins, Ian Marschner, Rachel O'Connell, Nanda Aryal, Val Gebski, Ian Marschner, John R. Simes, and Tony Keech.